Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
Completed · Phase 1 · Has a placebo group
Conditions studied: Cocaine Use Disorder
In brief
The overall goal of this project is to develop initial human data on effects of novel compounds on safety (interactions with cocaine) and efficacy (subjective response to cocaine and self administration data) in non-treatment seeking cocaine use disorder subjects. The compound to be studied will be the 5-HT2CR agonist lorcaserin. Lorcaserin and other 5-HT2CR agonists have been shown to reduce cocaine self-administration and cue reactivity in rodents. In addition there is human safety data in non-cocaine using subjects for lorcaserin as it is currently FDA approved for obesity, and safety data from a cocaine interaction study in rodents , but there is no human cocaine interaction/PK data and no PD data to support potential dosages for phase II clinical trials.
Key facts
- Study ID
- NCT02537873
- Run by
- Virginia Commonwealth University
- People needed
- 29
- Starts
- 2015-07-01
- Expected to finish
- 2018-07-19
- Last updated by the study team
- 2020-05-12
Who can join
Age: 18 and older, up to 59. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Virginia Commonwealth University, Institute for Drug and Alcohol Studies — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.